Enhanced accessibility and hydrophobicity of amyloidogenic intermediates of the β2-microglobulin D76N mutant revealed

Kazumasa Sakurai1, Ryosuke Tomiyama2

  • 1High Pressure Protein Research Center, Institute of Advanced Technology, Kindai University, Wakayama, Japan; Department of Biotechnology, Faculty of Biology-oriented Science and Technology, Kindai University, Wakayama, Japan.

Insights

Dialysis-related amyloidosis is caused by beta2-microglobulin (β2m). The D76N mutant shows enhanced amyloidogenicity due to altered folding pathways and a more hydrophobic intermediate state.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Folding

Background:

  • Beta2-microglobulin (β2m) is the protein responsible for dialysis-related amyloidosis.
  • Amyloidogenic precursor states, like the IT state, are crucial in protein misfolding diseases.
  • The D76N β2m variant is a naturally occurring mutant with increased amyloidogenicity.

Purpose of the Study:

  • To investigate the molecular mechanisms behind the enhanced amyloidogenicity of the D76N β2m mutant.
  • To compare the pressure-induced folding/unfolding equilibria of wild-type and D76N β2m.

Main Methods:

  • Utilized pressure-induced folding/unfolding equilibria.
  • Monitored intrinsic tryptophan and 1-anilino-8-naphthalene sulfonate fluorescence.
  • Analyzed kinetic data to determine differences in folding pathways and stability.

Main Results:

  • The D76N mutant exhibits different folding/unfolding behaviors compared to wild-type β2m.
  • Differences in activation energy and native state stability contribute to rapid IT state accumulation in D76N.
  • The IT state of D76N β2m is more hydrophobic, enhancing its amyloidogenicity.

Conclusions:

  • The altered folding pathway and increased hydrophobicity of the IT state in D76N β2m drive its enhanced amyloidogenicity.
  • These molecular changes correlate with distinct clinical symptoms observed in patients.
  • Stabilizing the native state of β2m is a potential therapeutic strategy to inhibit amyloid fibril formation.